The second LORENZ Connect attracted visitors from 25 countries to their screens!
Posted on May 19, 2021
The second LORENZ Connect virtually hosted participants from 25 countries as they tuned in to listen to global experts and health authorities discuss recent trends and topics affecting the Regulatory Affairs World today. With 27 speakers from all over the world, a wide variety of hot topics were covered in 18 sessions, including the technical rejection criteria for study data, RA efficiency through process optimization, global regulatory updates, and Health Canada updates. The conference began with a keynote address by our CEO Raoul-A. Lorenz, in which he presented LORENZ's achievements to date, the principles we strive for, and what's coming next. He underlined our ambition to offer you one seamless and flexible user experience by showing the new LORENZ Application Suite, which combines all of our business capabilities into one platform.
For those who registered but could not make it to the live presentations in the end, the recordings are already available in your LORENZ ID where you can watch them at your own pace. The PowerPoint presentations can also be found in your LORENZ ID.
Not only were the topics themselves top-notch, but so too were the speakers who took the time to prepare and give their presentations, as well as successfully answer tough questions during their Q&A. Therefore, we at LORENZ would like to express how grateful we are for all the hard work you put into it. Without our speakers, the second LORENZ Connect wouldn’t have been the big success it was.
We hope that you enjoyed the second LORENZ Connect and took away many useful insights. We were astounded by the number of participants and the overwhelmingly positive feedback! For anyone who's already interested in our next conference, be it online or on-site, we recommend saying “yes” to the email notifications in your LORENZ ID so you don’t miss any updates on future LORENZ events. If you haven’t yet registered for a LORENZ ID, now is a great time to sign on and stay up to date.
We would like to say thank you to
Dr. René Klünsch (Bayer AG), Jerianne Minervini (Bayer AG), Anna Sahl (Bayer AG), Dr. Ulrike Vollmer (Bayer AG), Jillian Carinci (Biogen Corporation), Steve Gens (Gens and Associates, Inc.), Kelly Hnat (Gens and Associates, Inc.), Melissa Andaya (Gilead Sciences, Inc.), Jessica Romero (Gilead Sciences, Inc.), Irena Pastorekova (Health Canada), Michelle Farmer (LORENZ Life Sciences Group), Massud Fazelly (LORENZ Life Sciences Group), Leonhard Keller (LORENZ Life Sciences Group), Raoul-A. Lorenz (LORENZ Life Sciences Group), Kristina Roberson (LORENZ Life Sciences Group), Prasanna Sadashivaiah (LORENZ Life Sciences Group), Dr. Katharina Schmitz (LORENZ Life Sciences Group), Akira Yamaguchi (LORENZ Life Sciences Group), Hans van Bruggen (Qdossier B.V.), Jim Czubachowski (Regeneron Pharmaceuticals, Inc.), Joseph Moy (Regeneron Pharmaceuticals, Inc.), Robert Pers (Regeneron Pharmaceuticals, Inc.), Vladlen Rotshteyn (Regeneron Pharmaceuticals, Inc.), Ginny Smith (United Therapeutics Corporation), Shannon Heacock (WAYS Pharmaceutical Services LLC), and Kelly Crossett (Whitsell Innovations, Inc.).
This entry was posted in LORENZ Events.